FR2954320B1 - Composition pharmaceutique orale suprabiodisponible contenant un acide biphosphonique ou un de ses sels - Google Patents

Composition pharmaceutique orale suprabiodisponible contenant un acide biphosphonique ou un de ses sels

Info

Publication number
FR2954320B1
FR2954320B1 FR0906126A FR0906126A FR2954320B1 FR 2954320 B1 FR2954320 B1 FR 2954320B1 FR 0906126 A FR0906126 A FR 0906126A FR 0906126 A FR0906126 A FR 0906126A FR 2954320 B1 FR2954320 B1 FR 2954320B1
Authority
FR
France
Prior art keywords
supplementally
salts
pharmaceutical composition
composition containing
oral pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0906126A
Other languages
English (en)
Other versions
FR2954320A1 (fr
Inventor
Thierry Breul
Claude Laruelle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CLL Pharma SA
Original Assignee
CLL Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CLL Pharma SA filed Critical CLL Pharma SA
Priority to FR0906126A priority Critical patent/FR2954320B1/fr
Priority to PCT/FR2010/000837 priority patent/WO2011080413A1/fr
Publication of FR2954320A1 publication Critical patent/FR2954320A1/fr
Application granted granted Critical
Publication of FR2954320B1 publication Critical patent/FR2954320B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0906126A 2009-12-17 2009-12-17 Composition pharmaceutique orale suprabiodisponible contenant un acide biphosphonique ou un de ses sels Expired - Fee Related FR2954320B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0906126A FR2954320B1 (fr) 2009-12-17 2009-12-17 Composition pharmaceutique orale suprabiodisponible contenant un acide biphosphonique ou un de ses sels
PCT/FR2010/000837 WO2011080413A1 (fr) 2009-12-17 2010-12-10 Composition pharmaceutique orale solide suprabiodisponible contenant un acide biphosphonique ou un de ses sels

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0906126A FR2954320B1 (fr) 2009-12-17 2009-12-17 Composition pharmaceutique orale suprabiodisponible contenant un acide biphosphonique ou un de ses sels

Publications (2)

Publication Number Publication Date
FR2954320A1 FR2954320A1 (fr) 2011-06-24
FR2954320B1 true FR2954320B1 (fr) 2012-06-15

Family

ID=42543434

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0906126A Expired - Fee Related FR2954320B1 (fr) 2009-12-17 2009-12-17 Composition pharmaceutique orale suprabiodisponible contenant un acide biphosphonique ou un de ses sels

Country Status (2)

Country Link
FR (1) FR2954320B1 (fr)
WO (1) WO2011080413A1 (fr)

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1201087B (it) 1982-04-15 1989-01-27 Gentili Ist Spa Bifosfonati farmacologicamente attivi,procedimento per la loro preparazione e relative composizioni farmaceutiche
FR2531088B1 (fr) 1982-07-29 1987-08-28 Sanofi Sa Produits anti-inflammatoires derives de l'acide methylenediphosphonique et leur procede de preparation
US4639338A (en) 1984-08-06 1987-01-27 Ciba-Geigy Corporation Preparation of crystalline disodium 3-amino-1-hydroxypropane-1,1-diphosphonate pentahydrate
IL77243A (en) 1984-12-21 1996-11-14 Procter & Gamble Pharmaceutical compositions containing geminal diphosphonic acid compounds and certain such novel compounds
DE3623397A1 (de) 1986-07-11 1988-01-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
DE3626058A1 (de) 1986-08-01 1988-02-11 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
ATE60711T1 (de) 1986-12-20 1991-02-15 Boehringer Mannheim Gmbh Clodronat-haltige arzneimittel und verfahren zur herstellung derselben.
CA1339805C (fr) 1988-01-20 1998-04-07 Yasuo Isomura Acide (cycloalkylamino) methylenebis phosphonique et medicaments le contenant comme ingredients actif
FR2629716B1 (fr) * 1988-04-07 1991-07-19 Sanofi Sa Composition pharmaceutique pour administration orale a base d'un derive d'acide diphosphonique
FR2703590B1 (fr) 1993-04-05 1995-06-30 Sanofi Elf Utilisation de derives d'acide bisphosphonique pour la preparation de medicaments destines a favoriser la reparation osseuse .
WO1997044017A1 (fr) 1996-05-17 1997-11-27 Merck & Co., Inc. Formulation de bisphosphonate efferverscente
SE9901272D0 (sv) 1999-04-09 1999-04-09 Astra Ab New improved formulation
AU7105501A (en) 2000-07-17 2002-01-30 Yamanouchi Pharma Co Ltd Pharmaceutical composition improved in peroral absorbability
US6638920B2 (en) * 2000-07-21 2003-10-28 Merck & Co., Inc. Compositions and methods of preventing or reducing the risk or incidence of skeletal injuries in horses
US7488496B2 (en) * 2002-03-06 2009-02-10 Christer Rosen Effervescent compositions comprising bisphosphonates and methods related thereto
DK2283825T3 (da) 2004-05-24 2022-06-27 Theramex Hq Uk Ltd Enterisk fast oral doseringsform af en bisfosfonat indeholdende et chelateringsmiddel
US7645459B2 (en) 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of bisphosphonates
AU2005275193A1 (en) 2004-07-15 2006-02-23 Nanobac Life Sciences Methods and compositions for the administration of calcium chelators, bisphosphonates and/or citrate compounds and their pharmaceutical uses
WO2006020009A1 (fr) * 2004-07-23 2006-02-23 The Procter & Gamble Company Dosage oral solide formant un bisphosphonate et contenant un agent chélateur
US20060134190A1 (en) 2004-12-16 2006-06-22 Banner Pharmacaps Inc. Formulations of bisphosphonate drugs with improved bioavailability
WO2006100527A1 (fr) * 2005-03-24 2006-09-28 Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. Comprime effervescent contenant de l’alendronate sodique, utilisation et procede associes
US7473684B2 (en) * 2005-09-16 2009-01-06 Selamine Limited Bisphosphonate formulation
KR101191322B1 (ko) * 2006-04-07 2012-10-16 메리온 리서치 Ⅲ 리미티드 증진제를 함유하는 고형 경구용 투여 제형
WO2009018834A1 (fr) 2007-08-06 2009-02-12 Pharmathen S.A. Composition pharmaceutique contenant du biphosphonate et son procédé de préparation
US20100215743A1 (en) * 2009-02-25 2010-08-26 Leonard Thomas W Composition and drug delivery of bisphosphonates

Also Published As

Publication number Publication date
FR2954320A1 (fr) 2011-06-24
WO2011080413A1 (fr) 2011-07-07

Similar Documents

Publication Publication Date Title
EP2100610A4 (fr) Composition pharmaceutique contenant de l'hydroxypropylcellulose faiblement substituée
BR112013008703A2 (pt) "método e sistema de indicador biológico de esterilização"
EP2349289A4 (fr) Compositions pharmaceutiques contenant de la diacéréine
EP2094118A4 (fr) Composition amelioree d'acide peracetique
EP2365941A4 (fr) Traitement de solutions ou d'eaux usées
BRPI0811110A2 (pt) Formulação de nicotina oral tamponada com aminoácido
EP2524056A4 (fr) Amplification multiplex pour la détection de variations d'acide nucléique
BRPI0812120A2 (pt) Formulação de nicotina oral revestida tamponada com aminoácido
EP2423228A4 (fr) Anticorps contenant igg2 ayant une mutation d'acide aminé introduite dans celui-ci
EP2394645A4 (fr) Utilisation médicale de dérivés d'acide 5-benzylaminosalicylique ou de sels correspondants
BR112012022317A2 (pt) composição de esterilização livre de molibdato contendo ácido peracético
EP2205218A4 (fr) Composition pharmaceutique contenant de l'ésoméprazole
EP2427417A4 (fr) Sels d'acide 3-penthylphénylacétique et utilisations pharmaceutiques de ceux-ci
EP2484697A4 (fr) Anticorps antipodoplanine et composition pharmaceutique contenant un anticorps antipodoplanine
DK2120585T3 (da) Langtidsfrigivet farmaceutisk sammensætning indeholdende vandig opløsning af bisfosfonat
EP2307056A4 (fr) Compositions pharmaceutiques aqueuses stables contenant du paracetamol
EP2468771A4 (fr) Composition pharmaceutique contenant un anticorps anti-hb-egf comme ingrédient actif
EP2242359A4 (fr) Synthèse de lactones d'acide résorcylique utiles en tant qu'agents thérapeutiques
EP2223697A4 (fr) Préparation contenant une bactérie d'acide lactique
FR2928919B1 (fr) Procede de preparation de l'acide difluoroacetique et de ses sels
BRPI1007194A2 (pt) Composição compreendendo ácido chicórico e/ou derivados do mesmo
EP2490534A4 (fr) Compositions pharmaceutiques de combinaisons d'inhibiteurs de dipeptidyle peptidase-4 avec la pioglitazone
EP2258426A4 (fr) Contenant de médicament
ZA200904543B (en) Salts, aqueous liquid compositions containing salts of S-(+)-abscisic acid and methods of their preparation
BRPI0914971A2 (pt) composições farmacêuticas que contêm fármaco antibiótico de fluoroquinolonas

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20140829